Biolinerx Ltd.
13F holders, Q2 2024 (June 30)31holders +3
6new positions
4sold out
$0.57avg. 13F price*
At the end of Q2 2024, 31 institutions reported holding Biolinerx Ltd. in their 13F filings, up 3 from Q1 2024. 6 opened new positions and 4 sold out. The largest holders were Alyeska Investment Group, L.P. ($1.1M), CVI Holdings, LLC ($462K) and Envestnet Asset Management Inc. ($122K).
- Company
- Biolinerx Ltd.
- CUSIP
- 09071M205
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.7M |
| Exits | 4 | $80K |
All 13F filers, Q1 2024 → Q2 2024: 3,230,114 shares bought and 401,599 shares sold, net +2,828,515 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Alyeska Investment Group, L.P. | 0.01% | New | 1,953,366 | $1.1M |
| CVI Holdings, LLC | 0.43% | New | 815,683 | $462K |
| Envestnet Asset Management Inc. | 0.00% | Add +293.0% | 213,833 | $122K |
| Values First Advisors, Inc. | 0.07% | Add +0.1% | 203,759 | $116K |
| PVG Asset Management Corp. | 0.28% | — | 123,580 | $70K |
| Susquehanna International Group, LLP | 0.00% | Reduce -42.3% | 118,180 | $67K |
| Atria Investments, Inc | 0.00% | New | 104,781 | $60K |
| Atria Wealth Solutions, Inc. | 0.00% | No change | 99,333 | $57K |
| LPL Financial LLC | 0.00% | Reduce -18.3% | 82,000 | $47K |
| Cetera Investment Advisers | 0.00% | Add +297.5% | 71,667 | $41K |
| Morgan Stanley | 0.00% | Reduce -76.5% | 68,437 | $39K |
| Wells Fargo & Company | 0.00% | Add +74.9% | 56,035 | $32K |
| Two Sigma Securities, LLC | 0.00% | Add +167.8% | 46,228 | $26K |
| Orin Green Financial, LLC | 0.01% | New | 43,000 | $25K |
| Rathbones Group PLC | 0.00% | No change | 39,820 | $23K |
| Geode Capital Management, LLC | 0.00% | No change | 39,993 | $23K |
| Geneos Wealth Management Inc. | 0.00% | No change | 38,500 | $22K |
| Gradient Investments LLC | 0.00% | Add +233.3% | 30,000 | $17K |
| Rhumbline Advisers | 0.00% | Add +40.4% | 25,741 | $15K |
| Weaver Consulting Group | 0.00% | New | 16,920 | $10K |
| Cutter & CO Brokerage, Inc. | 0.00% | No change | 16,667 | $10K |
| Creative Planning | 0.00% | Add +0.8% | 13,081 | $7K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -5.8% | 13,035 | $7K |
| Nemes Rush Group LLC | 0.00% | No change | 12,000 | $7K |
| NewEdge Advisors, LLC | 0.00% | No change | 4,300 | $2K |
| JPMorgan Chase & Co. | 0.00% | New | 1,501 | $850 |
| UBS Group AG | 0.00% | Reduce -88.2% | 1,480 | $844 |
| Osaic Holdings, Inc. | 0.00% | Add +16.6% | 1,406 | $801 |
| GAMMA Investing LLC | 0.00% | Reduce -94.5% | 218 | $124 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 200 | $114 |
| Royal Bank of Canada | 0.00% | No change | 66 | $0 |
"% of holder's portfolio" is BIOLINERX LTD's weight in each manager's 13F, not the share of Biolinerx Ltd. the manager owns.